Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
On July 1, 2024, Genasys Inc. (the “Company”) received notice from Caltha Seymour of her resignation from the Board of Directors of the Company effective immediately due to increasing demands of her employment.
The Board of Directors (the "Board") of Voya Financial, Inc. (the "Company") appointed William J. Mullaney as a director of the Company, effective as of July 5, 2024.
On July 1, 2024, the Board of Directors (the “Board”) of Allied Gaming & Entertainment Inc. (the “Company”) appointed Mr. Mao Sun to serve as a director on the Board, effective immediately.
As previously disclosed in the Proxy Statement, Dean Mitchell did not stand for re-election at 2024 Annual Meeting. Accordingly, Mr. Mitchell’s term on the Board ended effective as of July 5, 2024.
On July 5, 2024, Edgardo Baracchini informed INmune Bio Inc. (the “Company”) of his resignation from the board of directors of the Company (the “Board”), effective immediately.
Departed
Stanley P. Jaworski
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Departed
Richard Bravman
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Departed
John Guttilla
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Departed
Steve Smith
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Departed
Michael N. Taglich
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Departed
William Cooke
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Appointed
Micheal Stewart
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
At the Effective Time, Robert Newbold, Micheal Stewart and Steve Smith were appointed as directors of the Company.
Appointed
Steve Smith
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
At the Effective Time, Robert Newbold, Micheal Stewart and Steve Smith were appointed as directors of the Company.
Appointed
Robert Newbold
director
DecisionPoint Systems, Inc.
Effective
2024-07-05
Filed
July 5, 2024, 7:59 PM ET
At the Effective Time, Robert Newbold, Micheal Stewart and Steve Smith were appointed as directors of the Company.
On July 2, 2024, Christa Davies submitted her resignation from the Board of Directors (the “Board”) of Workday, Inc. (“Workday”), including from the Audit Committee of the Board (the “Audit Committee”), effective immediately.
Effective July 5, 2024, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Dr. Yujie Wang (“Dr. Wang”) as a member of the Board.
On July 1, 2024, Prudence Kuai informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of her intention to resign from the Board and all committees thereof, effective July 5, 2024.
Departed
Pilar Manchón
Director
TransparentBusiness, Inc.
Effective
2024-06-28
Filed
July 5, 2024, 7:59 PM ET
On June 28, 2024, the Board of Directors (the “Board”) of Unicoin Inc. (the “Company”) resolved that Pilar Manch ó n’s initial term as a director on the Board had expired and acknowledged that as of June 28, 2024, Ms. Manch ó n shall no longer serve on the Board.
Appointed
Silvina Moschini
Voting Member of the Board
TransparentBusiness, Inc.
Effective
2024-06-28
Filed
July 5, 2024, 7:59 PM ET
On June 28, 2024, the Board re-elected Silvina Moschini as a voting member of the Board, effective as of June 28, 2024.
Appointed
Ivona Smith
independent director
Vintage Wine Estates, Inc.
Effective
2024-06-28
Filed
July 3, 2024, 7:59 PM ET
Effective June 28, 2024, the Board of Directors (the “Board”) of Vintage Wine Estates, Inc. (the “Company”) appointed Ivona Smith as an independent director to the Board
on July 2, 2024, Mr. Bradley C. Barron was appointed to the board of directors (the “Board”) of Sunoco GP by the sole member of Sunoco GP pursuant to the provisions of the Amended and Restated Limited Liability Company Agreement of Sunoco GP dated September 25, 2012, as amended.
On June 28, 2024, Ashley M. Keating, a member of the Board of Directors (the “Board”) of Medpace Holdings, Inc. (the “Company”) notified the Company of her resignation, effective as of June 30, 2024.
The Board of the Company following a recommendation from the independent directors of the Board, unanimously approved that Dr. Dani S. Zander be elected to fill the Class III director vacancy on the Board of the Company, effective July 1, 2024
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
Departed
J. Bradley Campbell
Director
DELTA APPAREL, INC
Effective
2024-07-01
Filed
July 3, 2024, 7:59 PM ET
On July 1, 2024, J. Bradley Campbell resigned from service on the Company’s Board of Directors (the “Board”) and all subcommittees of the Board effective immediately.
On July 1, 2024, Cynthia Williams notified the Board of Directors (the “Board”) of Aterian Inc. (the “Company”) of her intent to not stand for reelection at the Company’s 2024 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board effective as of the the conclusion of the Annual Meeting.
On June 28, 2024, the Board of Directors (the “Board”) of STAG Industrial, Inc. (the “Company”) increased the size of the Board from 10 members to 11 members and appointed Vicki Lundy Wilbon to the Board, effective as of July 1, 2024, and subject to re-election at the next annual meeting of stockholders to be held in 2025.
Departed
Vito J. Mangiardi
Member of the Board of Directors
PRESSURE BIOSCIENCES INC
Effective
2024-06-18
Filed
July 3, 2024, 7:59 PM ET
Additionally, on June 18, 2024, Vito J. Mangiardi, a member of the Board, resigned, effective immediately.
Departed
Kevin A. Pollack
Member of the Board of Directors
PRESSURE BIOSCIENCES INC
Effective
2024-06-18
Filed
July 3, 2024, 7:59 PM ET
On June 18, 2024, Kevin A. Pollack, a member of the Board of Directors (the “Board”) of Pressure BioSciences, Inc. (the “Company”), resigned, effective immediately.
On July 1, 2024, each of Keith Ward, PhD and Praveen Tyle, PhD informed the Board of their intent to resign as a member of the Board, effective August 1, 2024.
the Board approved an increase in its authorized size from eight to nine members and appointed Karen L. Smith MD, PhD, MBA, LLM to fill the vacancy created by such increase.
On July 1, 2024, each of Keith Ward, PhD and Praveen Tyle, PhD informed the Board of their intent to resign as a member of the Board, effective August 1, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.